
Beige flag: Do global beauty brands understand Indian skin?
India's beauty boom in the last decade has put more ideas, products and beauty routines within our reach. But it's also made us more confused about what our skin does (and doesn't) need. Actors such as Deepika Padukone, Katrina Kaif, Kriti Sanon and Priyanka Chopra have launched beauty brands. Homegrown lines incorporate everything from K-beauty to Ayurveda. And dermatologists are busy at lunchtime, performing non-invasive anti-ageing, spot correcting treatments. We're moisturised, but we're hardly unbothered.
So, we asked experts the basics. What, given our ethnic diversity, does Indian skin even mean? What is smog doing to city skin that it isn't doing in less-polluted villages? What do Brown people worry about as they age, if not crow's feet? Does the Western formula for fillers and injectables work differently on Indian features? And crucially, which global beauty benchmarks just don't work for India? We're more than our skin colour, see how much more:
Is there such a thing as Indian skin?
Dermatologists typically use the Fitzpatrick scale, a set of deepening skin tones, to determine how much melanin pigment a person's skin contains. So far, so good. But on a scale of I to VI, people from India fall anywhere from Type III to VI. That's half the scale already, and we're only measuring colour.
We're just too diverse to be grouped under a set of skin colours, says Dr Satish Bhatia, board-certified MD, dermatologist and skin surgeon at the Indian Cancer Society Mumbai. Two people, who start life with the same skin colour, can still develop differences in their skin's ceramide levels and the structure, which can affect how the organ reacts to the environment and their own lifestyles.
A study published by market research group Kantar and the skincare brand Dermafique in 2023 identified the following characteristics of Indian skin: Higher melanin content, greater pigmentation, larger and deeper pores, and surprisingly, dryer skin. A bonus: Deeper skin tones also tend to be susceptible to post-inflammatory hyperpigmentation. So, breakouts leave scars, even vigorous rubbing can leave a dark cast.
They're the kinds of concerns Indians are familiar with, but which international brands (which advertise glow, suppleness and wrinkle-filling) often fail to address.
What concerns do people in India typically have with their skin?
All skin darkens in the sun. But for darker skin, prolonged exposure doesn't just cause a tan – UV radiation can cause dark blotches and can cause oily and dry patches to develop simultaneously. 'High-altitude regions such as parts of Himachal Pradesh and Uttarakhand may experience increased UV exposure, leading to pigmentation and sensitivity,' says Vivek Sahni, founder of Kama Ayurveda. Those facing the extreme weather variations of North India suffer from dry skin and flakiness. Along the coasts, the high humidity tends to trap bacteria in oily skins, resulting in more breakouts and scalp issues. Meanwhile, those in arid Rajasthan and Punjab, which rely on hard water with high mineral content, grapple with dry, irritable skin.
For those in big cities, air pollution can make skin appear dull and clog pores, making skin look older. 'Even within cities, lifestyle, diet, and stress levels play a role,' says Dr Chiranjiv Chhabra, chief dermatologist and founder of Alive Wellness Clinics, and skincare line Alive & Well. Our melanin-rich complexions make us more prone to hyperpigmentation from acne scars, sun damage or inflammation. So, what might be a quick pimple for someone else could leave behind a stubborn mark for us. The catch-all term Indian skin, it turns out, doesn't just defy geography, it also stumps biology.
What does ageing really mean for Brown people?
'Signs of ageing, such as crow's feet or fine lines appear much later on deeper skin tones compared to lighter ones, but when they arrive, they are often accompanied by textural changes and loss of elasticity,' says Sahni. 'We also tend to develop uneven skin tones owing to high UV exposure, and deal with sensitivity and inflammation triggered by pollution or harsh products.'
Whatever you do, don't run to the kitchen for a natural remedy. Not everything there is meant for your face despite what the soft-focus Insta Reel and an influencer's soothing voice-over says. Indians tend to use lemon juice and baking soda as topical applications, both harsh agents that can cause sensitivity or even burns. 'I don't recommend home, kitchen or Instagram remedies as they may lead to disastrous results without dermatological supervision,' says Dr Bhatia.
Remember those deep dense pores from the Kantar study? They get clogged easily. So, even when they're not causing breakouts, they're preventing expensive serums from sinking deep into the skin and doing their job. 'Exfoliation is key for Indian skin, so that skincare can perform well,' says Dr Geeta Grewal, cosmetic surgeon and founder of Gurugram-based 9 Muses wellness clinic. No. No scrubbing – that's just going to bring on hyperpigmentation. Use a mild chemical exfoliant instead.
Are injectables and professional treatments adapted for Indian faces?
We've seen what botched Botox and excess fillers can do to White celebrities: Too-full lips, comically rounded cheekbones, the eye area stretched back so tight, it looks almost anime. Of course, Indians are wary. Dr Grewal says we're not just afraid of the results, but also of being outed as adopting these measures.
Most clinics that offer fillers and treatments follow a template that was configured for rich, ageing, White women. Dr Chhabra warns against going for a style that is trending. The differences in Indians' bone structure, fat distribution and skin behaviour as we age can affect the way the treatments work.
Recent dermatology journals have highlighted how post-inflammatory hyperpigmentation is more common in skin of colour and how we need tailored protocols, especially for lasers and peels. Those haven't been introduced yet.
But some solutions work especially well for us Brown folks. Content creator and lifestyle influencer Gitika Gupta (@StyleStamper.Gitika) says she regularly gets platelet-rich-plasma injections, which inject the plasma from her own blood back into her skin, to give it a more youthful appearance. She also tried (and liked) a mono threads session, in which tiny threads are inserted into the skin to stimulate collagen production and give the face a lifted look. 'These treatments help if you want great skin as you age,' she says. But only a good dermatologist will be able to determine if they work on a particular individual.
Either way, regardless of where you fall on the Fitzpatrick scale, how oily your skin, how humid or arid your neighbourhood, how stressed you are, how your skin develops scars, and how much you're eyeing a collagen injection, 'sunscreen is an absolute must,' says Grewal. And no one should start any skincare routine or treatment without the advice of a licensed dermatologist.
From HT Brunch, June 14, 2025
Follow us on www.instagram.com/htbrunch
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
an hour ago
- Time of India
S&R, Saraf guide IHH's Fortis-Gleneagles hospital management tie-up in evolving Indian healthcare market
Advt By , ETLegalWorld Join the community of 2M+ industry professionals. Subscribe to Newsletter to get latest insights & analysis in your inbox. All about ETLegalWorld industry right on your smartphone! Download the ETLegalWorld App and get the Realtime updates and Save your favourite articles. S&R Associates represented Malaysia-headquartered IHH Healthcare Berhad , in the strategic collaboration between its Indian subsidiaries Fortis Healthcare Limited and Gleneagles Healthcare India , pursuant to which Fortis will manage the operations of five hospitals in the Gleneagles India network under an operation and maintenance services agreement. Saraf and Partners advised Fortis on the transaction reflects broader sectoral trends driving India's healthcare M&A activity , which saw deal volumes surge in H1 2025 despite a slight dip in total value. Private players are planning significant bed additions with a capital outlay of approximately INR 32,500 crore over five years, with particular focus on tier-2 and tier-3 city expansion and single-specialty hospitals in oncology, nephrology, and collaboration leverages IHH Healthcare Berhad's global integrated healthcare expertise with Fortis's established Indian market presence, positioning both entities to capitalize on India's expanding healthcare demand. The deal aligns with the domestic hospital sector's leadership in healthcare deal activity, as operators seek operational efficiencies and geographic expansion.S&R Associates' team was led by partners Rajat Sethi and Raya Hazarika, along with associate Stuti Dhundia. Head of competition practice Simran Dhir, partner Akshat Kulshrestha and associates Prerana De, Sehaj Mahajan and Ritik Mohapatra provided competition law advisory. Partner Niti Dixit advised on litigation transaction team led by senior partner Vaibhav Kakkar, partners Sahil Arora and Debarpan Ghosh. Partner Akshayy S Nanda's competition team assisted with regulatory compliance matters.
&w=3840&q=100)

Business Standard
an hour ago
- Business Standard
Rehab to ~25L cover: Find out how insured our athletes are against injuries
A career in sports could be financially rewarding. Medals and accompanying fame also add to the lure, nudging youngsters to take that leap. But there are pitfalls too, as injuries have cut short or reduced the career of many promising as well as established athletes worldwide. For many Indian athletes, especially those from modest backgrounds, a single accident can derail years of hard work and jeopardise their financial future. Medical bills pile up quickly, and the uncertainty of recovery can push families into debt. To provide athletes some cushion against such uncertainties, the government has rolled out several insurance and welfare initiatives. These government-backed schemes not just offer treatment, but provide financial cushioning to athletes, ensuring their focus remains on performance rather than the cost of recovery. Key national-level insurance schemes The Sports Authority of India (SAI) and the Ministry of Youth Affairs and Sports run multiple programmes that cover treatment and insurance for injuries: Pandit Deendayal Upadhyay National Welfare Programme: Provides up to ~10,00,000 for medical treatment to current and retired athletes or their families. This direct financial assistance plays a vital role in post-injury recovery. SAI Medical Insurance Schemes: Covers over 13,000 athletes, coaches and staff. Includes ~500,000 for general medical treatment and an additional ~25,00,000 for accidental death or severe injury. National Centre of Sports Sciences and Research (NCSSR): Offers specialised and subsidised treatment, injury management, and rehabilitation to athletes involved in national programmes, significantly reducing out-of-pocket healthcare costs. Central Athlete Injury Management System (CAIMS): Strengthens medical infrastructure, providing subsidised or free access to treatment facilities, indirectly relieving athletes from financial stress. State initiatives add more protection Several states are bolstering this ecosystem with their own athlete insurance policies: -Haryana offers a medical insurance cover of ~20,00,000 lakh for sportspersons. -Rajasthan's Mukhyamantri Sportsperson Beema Yojana provides ~10,00,000 cover and a ~20,000 monthly pension. What it means for athletes Reduced expenses: Access to government-funded treatment saves lakhs in private medical bills. Focused career building: With medical risks covered, athletes can train without financial anxiety. Caveats and the way forward However, there are gaps. These schemes mainly cover national-level athletes. Those at grassroots or in informal training systems remain uninsured. Awareness is another issue, athletes from rural areas often don't know such benefits exist.


Mint
an hour ago
- Mint
New IPO: NephroPlus files papers with Sebi for ₹353.4 crore IPO to expand Dialysis clinics
Nephrocare Health Services Limited, widely recognized under the brand name NephroPlus, has filed a Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) to raise ₹ 353.4 crore through an initial public offering (IPO). The Hyderabad-based company plans to use the proceeds to expand its network of dialysis clinics across India and repay outstanding debt, with the balance allocated to general corporate purposes. The IPO will include a fresh issue of equity shares worth ₹ 353.4 crore and an offer-for-sale (OFS) of up to 1.27 crore equity shares by promoter and non-promoter shareholders. Among the OFS participants are Investcorp Private Equity Fund II, Healthcare Parent Limited, Edoras Investment Holdings Pte. Ltd., and 360 One Special Opportunities Fund. The company may also consider a pre-IPO placement of up to ₹ 70.6 crore, which would reduce the size of the fresh issue accordingly. Established in 2009, NephroPlus has emerged as Asia's largest dialysis services provider and the fifth-largest globally in terms of the number of treatments performed in FY25, according to a Frost & Sullivan report. As of now, the company operates 447 clinics across 269 cities in 21 Indian states and 4 Union Territories, serving over 33,000 patients annually. NephroPlus commands more than 50 percent revenue market share in India's organised dialysis services market. NephroPlus has also made a significant push into international markets. It currently operates 34 clinics in the Philippines, 5 in Nepal, 4 in Uzbekistan, and recently entered Saudi Arabia in a bid to tap the Middle East healthcare market. The company's promoters include Vikram Vuppala, BVP Trust (Bessemer Venture Partners), and Investcorp-affiliated entities. As per the DRHP, NephroPlus will allocate ₹ 129.1 crore from the fresh issue proceeds towards setting up new dialysis clinics in India, which aligns with its strategy to grow its domestic footprint. An additional ₹ 136 crore will be used to pre-pay or repay certain existing borrowings, enhancing the company's financial flexibility and improving its balance sheet. In FY25, the company reported ₹ 755.8 crore in revenue from operations and a profit after tax of ₹ 67 crore, reflecting robust growth amid increasing demand for kidney care services. With chronic kidney disease (CKD) rising as the third fastest-growing cause of death globally, and diabetes and hypertension being its primary drivers, NephroPlus is well-positioned to benefit from secular health trends. ICICI Securities, Ambit Private Limited, IIFL Capital Services, and Nomura Financial Advisory and Securities (India) are acting as Book Running Lead Managers (BRLMs) for the IPO. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.